Pharmaceutical News

New ‘In Vivo’ Cell Therapies: A Breakthrough in Medicine Getting Closer to Reality

/ April 22, 2026

A new and exciting type of medical treatment called ‘in vivo cell therapy’ is now being tested for the first […]

/ April 21, 2026

Eli Lilly, the company behind the newly approved obesity medication called Foundayo (also known as orforglipron), has shared exciting new

/ April 20, 2026

A recent study has found that using food packaging films to store certain medications can help maintain their stability, especially

/ April 19, 2026

Amgen, a biotechnology company, has shared promising results from a large clinical trial (Phase 3) testing a new under-the-skin injection

/ April 18, 2026

Two major drug companies, Eli Lilly and Eisai, are defending their Alzheimer’s disease treatments after a new review suggested they

/ April 17, 2026

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new medication called Kerendia (finerenone) for adults with

/ April 15, 2026

Gilead Sciences, a well-known pharmaceutical company, has agreed to purchase Tubulis, a German biotechnology company, for $3.15 billion upfront. This

/ April 14, 2026

Kainova Therapeutics has started enrolling patients in Europe for an important early-stage clinical trial called the DOMISOL study. This trial

/ April 13, 2026

The United States Pharmacopeia (USP), a nonprofit organization that sets quality standards for medicines, has issued a new report highlighting

/ April 12, 2026

This week, several important updates in the pharmaceutical industry could affect how medicines and vaccines are developed, distributed, and supplied